(R)-Elagolix
Cat. No.:YN320913
| 产品名称: | (R)-Elagolix | 
| CAS No.: | 834153-87-6 | 
| Chemical Name: | 4-[[(1R)-2-[5-(2-Fluoro-3-methoxyphenyl)-3-[[2-fluoro-6-(trifluoromethyl)phenyl]methyl]-3,6-dihydro-4-methyl-2,6-dioxo-1(2H)-pyrimidinyl]-1-phenylethyl]amino]butanoic Acid;(R)-4-((2-(5-(2-Fluoro-3-methoxyphenyl)-3-(2-fluoro-6-(trifluoromethyl)benzyl)-4-me | 
| Synonyms: | NBI-56418 | 
| 分子量: | 631.59 | 
| 分子式: | C₃₂H₃₀F₅N₃O₅ | 
| SMILES: | FC1=C(C2=C(C)N(CC3=C(C(F)(F)F)C=CC=C3F)C(N(C[C@](C4=CC=CC=C4)([H])NCCCC(O)=O)C2=O)=O)C=CC=C1OC | 
| 存储: | Please store the product under the recommended conditions in theCertificate of Analysis. | 
| 运输: | Room temperature in continental US; may vary elsewhere. | 
| 产品描述: | Elagolix是一种高度有效的, 选择性, 口服活性的, 短期的, 非肽类促性腺激素释放激素受体 (GnRH受体) 拮抗剂 (KD = 54 pM)。 | 
| IC50和靶点: | |
| In Vitro: | |
| In Vivo: | |
| Clinical Trial: | |
| Solvent & Solubility: | 
Barra, F., et al.: Expert. Opin. Pharmaco. (2020)
Gotteland, J.-P., et al.: PCT Int. Appl. 268pp. (2020)